REGENXBIO Inc. (RGNX) Return on equity 2016–2025
REGENXBIO Inc. (RGNX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-188.7%FY2025 · since FY2016: -38.9% → -188.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -188.7% | -101.3 pp |
| FY2024 | -87.5% | -2.9 pp |
| FY2023 | -84.5% | -30.2 pp |
| FY2022 | -54.3% | -71.0 pp |
| FY2021 | 16.7% | +46.2 pp |
| FY2020 | -29.5% | -8.4 pp |
| FY2019 | -21.0% | -40.7 pp |
| FY2018 | 19.6% | +59.6 pp |
| FY2017 | -40.0% | -1.0 pp |
| FY2016 | -38.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Gross marginRGNX Operating incomeRGNX Operating marginRGNX Operating cash flowRGNX Free cash flowRGNX Capital expendituresRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Total liabilitiesRGNX Shareholders’ equityRGNX overview →